» Articles » PMID: 15896849

Estimation of Free Radical Formation by Beta-ray Irradiation in Rat Liver

Overview
Specialty Biochemistry
Date 2005 May 18
PMID 15896849
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo free radical reactions in rat liver as a result of exposure to low-dose beta-radiation was evaluated with electron paramagnetic resonance (EPR) spectroscopy by monitoring the reduction of the nitroxyl spin probe after intravenous administration. The EPR signal intensity of a nitroxyl probe as a function of time in bile flow was monitored by cannulating the bile duct through the cavity of an X-band EPR spectrometer. The results show that the rate of nitroxyl signal loss was higher in rats whose livers were exposed to beta-rays compared to unexposed rats. However, the rate of signal loss was lower in animals whose organs were exposed to air by opening the abdominal cavity. In vitro experiments also showed that the nitroxyl EPR signal loss was greater in an atmosphere of nitrogen than in air. Results suggest that under low levels of tissue oxygen, exposure to beta-rays results in nitroxyl signal loss, which may be mediated by free radical dependent pathways. When tissue oxygen were higher, hydrogen peroxide mediated oxidation of hydroxylamine may predominate resulting in a signal loss of smaller magnitudes. This study shows possible evidence of reactive oxygen species formation by low-dose beta-ray irradiation in a living animal.

Citing Articles

Preclinical Characterization of the Radioimmunoconjugate In or Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate.

Funase Y, Nakamura E, Kajita M, Saito Y, Oshikiri S, Kitano M J Nucl Med. 2020; 62(2):232-239.

PMID: 32737245 PMC: 8679590. DOI: 10.2967/jnumed.120.245837.


Effects of oxygen challenging to tissue redox and pO status.

Matsumoto K, Mitchell J, Krishna M Free Radic Biol Med. 2018; 130:343-347.

PMID: 30391676 PMC: 8202967. DOI: 10.1016/j.freeradbiomed.2018.10.454.


Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.

Carter L, Poty S, Sharma S, Lewis J J Labelled Comp Radiopharm. 2018; 61(9):611-635.

PMID: 29412489 PMC: 6081268. DOI: 10.1002/jlcr.3612.


Redox- and hypoxia-responsive MRI contrast agents.

Do Q, Ratnakar J, Kovacs Z, Sherry A ChemMedChem. 2014; 9(6):1116-29.

PMID: 24825674 PMC: 4119595. DOI: 10.1002/cmdc.201402034.


Brain redox imaging.

Matsumoto K, Hyodo F, Anzai K, Utsumi H, Mitchell J, Krishna M Methods Mol Biol. 2011; 711:397-419.

PMID: 21279614 PMC: 7398424. DOI: 10.1007/978-1-61737-992-5_20.